Katerina Nikolitch, MD, MSc

University of Ottawa Institute of Mental Health Research at The Royal, Ottawa, Canada; Department of Psychiatry, McGill University, Montreal, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada

  • 2Articles
  • 4.9KReads
  • 2018–2025Active
  • 5Collaborators
  • 8Citations

About

Katerina Nikolitch, MD, MSc, is affiliated with the University of Ottawa Institute of Mental Health Research, McGill University, and the University of Ottawa Department of Psychiatry. Her publications in Psychiatrist.com focus on major depressive disorder and schizophrenia/schizoaffective disorders, including studies on pharmacological treatments such as levomilnacipran and duloxetine, as well as factors influencing adherence to follow-up care in first-episode psychosis. Her work spans from 2018 to 2025 and includes collaboration with researchers like Andrew Ryder and Pierre Blier.

Publications

JCP
Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range
Original Research

Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range

August 25, 2025

Levomilnacipran and duloxetine are both potent serotonin reuptake inhibitors at all therapeutic regimens for MDD. Potent norepinephrine reuptake inhibition can be achieved from initiation with levomilnacipran, in contrast to...
, , , et al
PCC
Article

Adherence to Follow-Up in First-Episode Psychosis: Ethnicity Factors

June 7, 2018

Do visible minority patients have poorer service engagement and follow-up in mental health care in Canada? The objective of this study was to determine whether visible minority patients with...
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe